ÐÂÏã¸ÛÁùºÏ²Ê¿ª½±½á¹û

XClose

ÐÂÏã¸ÛÁùºÏ²Ê¿ª½±½á¹ûModule Catalogue

Home
Menu

Women's Cancer (IFWH0001)

Key information

Faculty
Faculty of Population Health Sciences
Teaching department
ÐÂÏã¸ÛÁùºÏ²Ê¿ª½±½á¹ûElizabeth Garrett Anderson Institute for Women's Health
Credit value
30
Restrictions
This module is specifically designed for Year 3 ÐÂÏã¸ÛÁùºÏ²Ê¿ª½±½á¹ûmedical students completing an integrated BSc and external medical students interrupting their studies to take the iBSc Women's Health at UCL. The module is compulsory for students on the iBSc Women's Health.
Timetable

Alternative credit options

There are no alternative credit options available for this module.

Description

The primary focus of this module is to present the scientific basis of prevention, early diagnosis, care and survivorship in breast, ovarian/fallopian tube, endometrial and cervical cancer. The module also examines how geographical and socioeconomic context influences the ability to deliver optimum care, and the impact of geographical, socioeconomic and lifestyle factors on outcomes in cancer. The module is delivered by experts in the field who outline the latest developments in cancer screening, management, psychological therapies, genetics, proteomics and epigenetic profiling, and immunological aspects of gynaecological cancers. The module also includes clinical observations/visits to the UCLH Macmillan Cancer Centre which underpin the Summative Assessment on the module.

After taking this module, you should have an overview of ovarian, breast, cervical and endometrial cancer with a focus on the patient’s pathway/experience and have explored the areas of unmet need and controversies in some key areas such as breast screening. Further, you will be able to:

  • Understand risk prediction and prevention strategies
  • Describe screening approaches, highlighting the challenges inherent in established programmes.
  • Critically appreciate the diagnostic tools in clinical use and novel technologies to aid earlier detection of women's cancers, with a focus on the biomarkers and imaging used in clinical practice. Recent advances in biomarker discovery are addressed through sessions on proteomics and epigenetics, and a practical session to outline how these technologies advance our knowledge in the early detection of women’s cancers in practice.
  • Understand the treatment and care in women’s cancers and the appropriateness of different treatment modalities (surgery, radiotherapy and chemotherapy) and novel (targeted) treatments.
  • Discuss cancer survivorship and critically consider the role of voluntary sector organisations and patient support groups
  • Understand end of life care for women with breast and reproductive cancers.

The module is mainly face-to-face classroom based learning involving lectures, student presentations, quizzes, seminars and discussions around required reading.

Introductory reading:

Mukherjee S. (2010) The emperor of all maladies: a biography of cancer 4th Estate, London.

Tobias JS, Hochhauser D. (2014) Cancer and its management. 7th Edition, John Wiley, Oxford.

Picardie R. (1998) Before I say goodbye. Penguin, London.

Module deliveries for 2024/25 academic year

Intended teaching term: Terms 1 and 2 ÌýÌýÌý Undergraduate (FHEQ Level 6)

Teaching and assessment

Mode of study
In person
Methods of assessment
30% Fixed-time remote activity
70% Coursework
Mark scheme
Numeric Marks

Other information

Number of students on module in previous year
28
Module leader
Dr Aleksandra Gentry-maharaj
Who to contact for more information
ifwhadminteam@ucl.ac.uk

Last updated

This module description was last updated on 8th April 2024.

Ìý